HealthEquity, Inc. (HQY) — Financial statements
Income statement, balance sheet, and cash flow for HealthEquity, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,313↑9.5% | 1,200↑20.0% | 1,000↑16.0% | 862↑13.9% | 757 | |
| Cost of Revenue | 400↓21.1% | 507↑8.0% | 470↑0.7% | 466↑12.2% | 416 | |
| Gross Profit | 913↑31.8% | 693↑30.7% | 530↑34.0% | 396↑16.0% | 341 | |
| Operating Expenses | ||||||
| R&D Expenses | 263↑9.6% | 240↑9.5% | 219↑13.2% | 193↑22.9% | 157 | |
| General & Administrative Expenses | 233↑76.1% | 132↑27.6% | 104↑8.4% | 96↑13.3% | 84 | |
| Selling & Marketing Expenses | 95↑5.0% | 91↑14.5% | 79↑15.1% | 69↑17.5% | 59 | |
| SG&A Expenses | 328↑47.2% | 223↑21.9% | 183↑11.2% | 164↑15.0% | 143 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 591↑27.7% | 463↑15.1% | 402↑12.3% | 358↑19.1% | 300 | |
| Total Costs & Expenses | 991↑2.2% | 970↑11.3% | 871↑5.7% | 824↑15.1% | 716 | |
| Operating Results | ||||||
| Operating Income | 322↑40.2% | 230↑79.6% | 128↑240.3% | 38↓7.2% | 41 | |
| Depreciation & Amortization | 0.00↓100.0% | 162↑6.1% | 153↓5.0% | 161↑17.5% | 137 | |
| EBITDA | 322↓4.5% | 338↑19.5% | 282↑64.6% | 172↑66.6% | 103 | |
| EBIT | 322↑84.2% | 175↑35.4% | 129↑1152.3% | 10↑130.2% | -34 | |
| Interest & Other Income | ||||||
| Net Interest Income | -45↑3.6% | -47↓7.9% | -43↑7.2% | -47↓33.0% | -35 | |
| Interest Income | 12↓13.0% | 14↑14.6% | 12↑588.5% | 2↑17.5% | 2 | |
| Interest Expense | 57↓5.8% | 61↑9.3% | 55↑14.5% | 48↑32.4% | 37 | |
| Non-Operating Income | 0.00↓100.0% | 55↑4666.2% | -1↓104.4% | 27↓63.5% | 75 | |
| Other Income / Expenses | -45↑60.5% | -114↓114.8% | -53↑29.9% | -76↑29.4% | -107 | |
| Income Before Tax | 277↑139.1% | 116↑54.6% | 75↑297.0% | -38↑42.9% | -67 | |
| Income Tax Expense | 62↑221.9% | 19↑0.0% | 19↑261.7% | -12↑46.8% | -22 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 215↑122.5% | 97↑73.6% | 56↑313.1% | -26↑41.0% | -44 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 215↑122.5% | 97↑73.6% | 56↑313.1% | -26↑41.0% | -44 | |
| Bottom-Line Net Income | 215↑122.5% | 97↑73.6% | 56↑313.1% | -26↑41.0% | -44 | |
| EPS (Basic) | 2.50↑125.2% | 1.11↑70.8% | 0.65↑309.7% | -0.31↑41.5% | -0.53 | |
| EPS (Diluted) | 2.46↑125.7% | 1.09↑70.3% | 0.64↑306.5% | -0.31↑41.5% | -0.53 | |
| Weighted Average Shares | 86↓0.8% | 87↑1.5% | 86↑1.3% | 84↑1.6% | 83 | |
| Weighted Average Diluted Shares | 87↓1.5% | 89↑2.2% | 87↑3.0% | 84↑1.6% | 83 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.